TCRT Stock Analysis: Buy, Sell, or Hold?
TCRT - Alaunos Therapeutics, Inc. Common Stock
$2.93
-0.02 (-0.68%)
▼
5d:
-2.66%
30d:
-12.8%
90d:
-9.29%
BUY
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 21, 2026
Get Alerted When TCRT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TCRT shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: TCRT shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: TCRT is currently trading at $2.93, which is considered oversold relative to its 30-day fair value range of $3.00 to $3.43.
Technical Outlook: Technically, TCRT is in a downtrend. Immediate support is located at $2.67, while resistance sits at $3.31.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $1.75. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TCRT is in a downtrend. Immediate support is located at $2.67, while resistance sits at $3.31.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $1.75. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$3.00 -
$3.43
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 40.3% above Wall St target ($1.75)
Fair Price Analysis
30-Day Fair Range
$3.00 -
$3.43
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$2.67
Resistance Level
$3.31
Current Trend
Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.48
Wall Street Target
$1.75
(-40.3%)
Revenue Growth (YoY)
100.0%
Share & Embed Analysis
Last updated: April 06, 2026 2:37 AM ET
Data refreshes hourly during market hours. Next update: 3:37 AM
Data refreshes hourly during market hours. Next update: 3:37 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TCRT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 56 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$132 | 58 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 60 HOLD |
